SCHEMBL10580149

SCHEMBL10580149

COc1cc(S(C)(=O)=O)ccc1-c1nc2cc(C(C)(C)C#N)ccc2[nH]1

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CDK4 P11802 1/20 0.41
▸ CCNA2 P20248 1/20 0.41
▸ CCND1 P24385 1/20 0.41
▸ CDK2 P24941 1/20 0.41
▸ CCND3 P30281 1/20 0.41
▸ NR1I2 O75469 3/20 0.40
▸ NPBWR1 P48145 1/20 0.38
▸ PDE5A O76074 1/20 0.37
▸ PDE3B Q13370 1/20 0.37
▸ PDE3A Q14432 1/20 0.37
▸ SCD O00767 5/20 0.37
▸ AMY1A P0DUB6 2/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ PDPK1 O15530 1/20 0.36
▸ CBFB Q13951 1/20 0.36
▸ FADS1 O60427 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10580157 0.92 CDK4 (0.47) CDK4CCNA2CCND1CDK2CCND3
SCHEMBL10760630 0.86 CDK4 (0.43) CDK4CCNA2CCND1CDK2CCND3
SCHEMBL11021893 0.84 ATR (0.44) CDK4CCNA2CCND1CDK2CCND3
SCHEMBL10577379 0.83 CDK4 (0.40) CDK4CCNA2CCND1CDK2CCND3
SCHEMBL10579306 0.83 CDK4 (0.38) CDK4CCNA2CCND1CDK2CCND3
SCHEMBL10577387 0.82 CDK4 (0.39) CDK4CCNA2CCND1CDK2CCND3
SCHEMBL10578096 0.82 AMY1A (0.37) PDE5APDE3BPDE3AAMY1APDPK1
SCHEMBL10765238 0.81 CDK4 (0.45) CDK4CCNA2CCND1CDK2CCND3
SCHEMBL10762025 0.78 CDK4 (0.59) CDK4CCNA2CCND1CDK2CCND3
SCHEMBL10763240 0.78 CDK4 (0.45) CDK4CCNA2CCND1CDK2CCND3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4882342-A CARDIOVASCULAR DISORDERS BOEHRINGER MANNHEIM GMBH (DE) 1989-11-21 — — US disclosed
EP-0266558-A2 5-Alkylbenzimidazoles, process for their preparation and medicaments containing them Roche Diagnostics GmbH (DE) 1988-05-11 — — EP disclosed
Send feedback